Correlation Between Sejong Telecom and Sk Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Sejong Telecom and Sk Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sejong Telecom and Sk Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sejong Telecom and Sk Biopharmaceuticals Co, you can compare the effects of market volatilities on Sejong Telecom and Sk Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sejong Telecom with a short position of Sk Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sejong Telecom and Sk Biopharmaceutica.
Diversification Opportunities for Sejong Telecom and Sk Biopharmaceutica
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sejong and 326030 is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Sejong Telecom and Sk Biopharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sk Biopharmaceuticals and Sejong Telecom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sejong Telecom are associated (or correlated) with Sk Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sk Biopharmaceuticals has no effect on the direction of Sejong Telecom i.e., Sejong Telecom and Sk Biopharmaceutica go up and down completely randomly.
Pair Corralation between Sejong Telecom and Sk Biopharmaceutica
Assuming the 90 days trading horizon Sejong Telecom is expected to under-perform the Sk Biopharmaceutica. But the stock apears to be less risky and, when comparing its historical volatility, Sejong Telecom is 2.12 times less risky than Sk Biopharmaceutica. The stock trades about -0.29 of its potential returns per unit of risk. The Sk Biopharmaceuticals Co is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 10,790,000 in Sk Biopharmaceuticals Co on September 26, 2024 and sell it today you would lose (340,000) from holding Sk Biopharmaceuticals Co or give up 3.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Sejong Telecom vs. Sk Biopharmaceuticals Co
Performance |
Timeline |
Sejong Telecom |
Sk Biopharmaceuticals |
Sejong Telecom and Sk Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sejong Telecom and Sk Biopharmaceutica
The main advantage of trading using opposite Sejong Telecom and Sk Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sejong Telecom position performs unexpectedly, Sk Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will offset losses from the drop in Sk Biopharmaceutica's long position.Sejong Telecom vs. Sam Chun Dang | Sejong Telecom vs. SAMRYOONG CoLtd | Sejong Telecom vs. BYON Co | Sejong Telecom vs. Sangsangin Co |
Sk Biopharmaceutica vs. ABL Bio | Sk Biopharmaceutica vs. ALTEOGEN | Sk Biopharmaceutica vs. Kmw Inc | Sk Biopharmaceutica vs. Celltrion Pharm |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |